Education
About Us
Working with TipRanks
Follow Us
Oncopeptides AB (SE:ONCO)
:ONCO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 31.65M | kr 35.22M | kr 8.36M | kr 118.30M | kr 0.00 |
| Gross Profit | kr 28.98M | kr 36.30M | kr 8.35M | kr 65.17M | kr -14.40M |
| Operating Income | kr -283.50M | kr -253.45M | kr -349.35M | kr -1.42B | kr -1.59B |
| EBITDA | kr -261.81M | kr -231.62M | kr -319.62M | kr -1.40B | kr -1.58B |
| Net Income | kr -284.61M | kr -249.11M | kr -337.95M | kr -1.43B | kr -1.59B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 178.54M | kr 173.44M | kr 344.51M | kr 364.30M | kr 852.48M |
| Total Assets | kr 244.19M | kr 238.38M | kr 385.32M | kr 439.38M | kr 946.76M |
| Total Debt | kr 141.72M | kr 126.16M | kr 9.54M | kr 14.19M | kr 19.36M |
| Net Debt | kr -36.82M | kr -47.25M | kr -334.97M | kr -347.99M | kr -820.90M |
| Total Liabilities | kr 189.91M | kr 181.60M | kr 91.03M | kr 228.51M | kr 369.86M |
| Stockholders' Equity | kr 54.28M | kr 56.78M | kr 294.29M | kr 210.87M | kr 576.90M |
| Cash Flow | |||||
| Free Cash Flow | kr -260.57M | kr -279.61M | kr -423.02M | kr -1.52B | kr -1.31B |
| Operating Cash Flow | kr -260.57M | kr -279.49M | kr -420.51M | kr -1.52B | kr -1.30B |
| Investing Cash Flow | kr 496.00K | kr -116.00K | kr -2.51M | kr -339.00K | kr -20.13M |
| Financing Cash Flow | kr 263.81M | kr 106.89M | kr 392.40M | kr 1.03B | kr 1.32B |